Kyverna Therapeutics Competitors and Similar CompaniesClear all

Kyverna Therapeutics's competitors and similar companies include Biosyntia, Jazz Pharmaceuticals, Spexis and AlzProtect.

	Kyverna Therapeutics Kyverna Therapeutics is a pharmaceutical company that generates treatments and potential cures for autoimmune diseases.	Biosyntia Biosyntia is a biotech company that specializes in synthetic biology and metabolic engineering.	Jazz Pharmaceuticals Jazz Pharmaceuticals is a biopharmaceutical company engaged in developing and marketing medicines for sleep disorders, epilepsy, and oncology.	Spexis Spexis (formerly known as Polyphor) is a bioengineering company that specializes in respiratory therapeutics.	AlzProtect AlzProtect is a biopharmaceutical company discovering and developing drug candidates for the treatment of neurodegenerative diseases.
Founding Date	Founding Date 2018	Founding Date 2012	Founding Date 2003	Founding Date 1996	Founding Date 2007
Type	Type Public	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare bioengineering drug development pharma	Tags Healthcare bioengineering biotech drug development pharma	Tags Healthcare drug development mental health oncology pharma	Tags Healthcare bioengineering biotech drug development pharma	Tags Healthcare bioengineering drug development pharma
Locations	Locations Emeryville, US HQ	Locations København, DK HQ	Locations Dublin, IE HQ Mississauga, CA Vancouver, CA Lyon, FR München, DE Roscommon, IE Villa Guardia, IT see more	Locations Allschwil, CH HQ	Locations Loos, FR HQ Loos, FR
Employees	Employees 84	Employees 22	Employees 2,800	Employees 50	Employees 1011% increase
Valuation ($)	Valuation ($) 230.8 m	Valuation ($) N/A	Valuation ($) 6.9 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $4.3b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($161.3m) (FY, 2025)	Net income N/A	Net income ($356.1m) (FY, 2025)	Net income (CHF19.6m) (FY, 2023)	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 4.7m (about 8 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 17.1m (over 8 years ago)
Total funding raised	Total funding raised $ 25m	Total funding raised $ 6.6m	Total funding raised $ 384.1m	Total funding raised N/A	Total funding raised $ 19.8m